This bill has the potential to reverse almost every pro-life effort made in Illinois and will protect abortion if regulated, defunded or o...
December 16, 2015
Rep. Smith’s Bipartisan Stem Cell Bill Heads to the President’s Desk
Smith and lead co-sponsor Rep. Doris Matsui shepherded the bill through the House last summer with the support of Reps. David Jolly (R-FL) and Chaka Fattah (D-PA), and worked with Senators Orrin Hatch (R-UT), Jack Reed (R-RI), Richard Burr (R-NC) and Al Franken (D-MN) who championed the bill in the Senate, making helpful modifications and sending it back to the House for one final vote of approval today.
As adopted by both chambers, H.R. 2820 now ensures that two collaborative programs that support treatment and therapies derived from adult stem cell lines will continue to receive funding through 2020. Under the legislation, the C.W. Bill Young Cell Transplantation Program will be authorized for five years at $30 million annually, while the National Cord Blood Inventory (NCBI) is authorized at $23 million annually for a five year period. Smith authored the original law (The Stem Cell Therapeutic and Research Act of 2005—P.L. 109-129) that created the national cord blood program and expanded the C.W. Bill Young Cell Transplantation Program.
Click here for the originating article from the office of pro-life Rep. Chris Smith